Challenges in defining and improving osteoporosis quality of care

Clinical and Experimental Rheumatology

Volumn 25, Issue 6 SUPPL. 47, 2007, Pages

  Warriner, Amy ^b   Curtis, Jeffrey R ^b   Saag, Kenneth G ^a  

^a The University of Alabama at Birmingham   (United States)

^b NONE

Author keywords

Bone fractures; Health care system; Osteoporosis; Patient compliance; Physician performance; Quality of health care

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; ESTROGEN; GLUCOCORTICOID; VITAMIN D;

ARTICLE; BONE DENSITY; CLINICAL PROTOCOL; CORTICOSTEROID INDUCED OSTEOPOROSIS; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC PROCEDURE; FRAGILITY FRACTURE; HEALTH CARE COST; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HUMAN; MORBIDITY; MORTALITY; OSTEOPOROSIS; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RISK FACTOR; SCREENING;

FEMALE; HUMANS; OSTEOPOROSIS; QUALITY OF HEALTH CARE;

EID: 36549020118     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. BURGE R, DAWSON-HUGHES B, SOLOMON DH, WONG JB, KING A, TOSTESON A: Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res 2007; 22: 465-75.
2. SOLBERG LI, CRAIN AL, SPERL-HILLEN JM, HROSCIKOSKI MC, ENGEBRETSON KI, O'CONNOR PJ: Care quality and implementation of the chronic care model: A quantitative study. Ann Fam Med 2006; 4: 310-6.
3. NHQA: The State of Health Care Quality 2004 www.ncqa.org/communications/ SOMC/SOHC2004.pdf.
4. NHQA: The State of Health Care Quality 2005 www.ncqa.org/communications/ SOMC/SOHC2005.pdf.
5. INSTITUTE OF MEDICINE COMMITTEE ON QUALITY OF HEALTH CARE IN AMERICA: Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC, National Academy Press, 2001.
6. CMS PVRP: http://www.cms.hhs.gov/PVRP/.
7. KING AB, SAAG KG, BURGE RT, PISU M, GOEL N: Fracture Reduction Affects Medicare Economics (FRAME): Impact of increased osteoporosis diagnosis and treatment. Osteoporos Int 2005; 16: 1545-57.
8. ANDRADE SE, MAJUMDAR SR, CHAN KA et al.: Low frequency of treatment of osteoporosis among post-menopausal women following a fracture. Arch Intern Med 2003; 163: 2052-7.
9. CUDDIHY MT, GABRIEL SE, CROWSON CS et al.: Osteoporosis intervention following distal forearm fractures: A missed opportunity? Arch Intern Med 2002; 162: 421-6.
10. ELLIOT-GIBSON V, BOGOCH ER, JAMAL SA, BEATON DE: Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: A systematic review. Osteoporos Int 2004; 15: 767-78.
11. FELDSTEIN A, ELMER PJ, ORWOLL E, HERSON M, HILLIER T: Bone mineral density measurement and treatment for osteoporosis in older individuals with fractures: A gap in evidence-based practice guideline implementation. Arch Intern Med 2003; 163: 2165-72.
12. HAJCSAR EE, HAWKER G, BOGOCH ER: Investigation and treatment of osteoporosis in patients with fragility fractures. CMAJ 2000; 163: 819-22.
13. MAJUMDAR SR, ROWE BH, FOLK D et al.: A controlled trial to increase detection and treatment of osteoporosis in older patients with a wrist fracture. Ann Intern Med 2004; 141: 366-73.
14. SIRIS ES, BILEZIKIAN JP, RUBIN MR et al.: Pins and plaster aren't enough: A call for the evaluation and treatment of patients with osteoporotic fractures. J Clin Endocrinol Metab 2003; 88: 3482-6.
15. JUBY AG, DE GEUS-WENCESLAU CM: Evaluation of osteoporosis treatment in seniors after hip fracture. Osteoporos Int 2002; 13: 205-10.
16. The National Osteoporosis Foundation, www.nof.com.
17. CURTIS JR, KIM Y, BRYANT T, ALLISON J, SCOTT D, SAAG KG: Osteoporosis in the home health care setting: A window of opportunity? Arthritis Rheum 2006; 55: 971-5.
18. COLON-EMERIC C, LYLES KW, LEVINE DA et al.: Prevalence and predictors of osteoporosis treatment in nursing home residents with known osteoporosis or recent fracture. Osteoporos Int 2007; 18: 553-9.
19. CURTIS JR, WESTFALL AO, ALLISON JJ et al.: Longitudinal patterns in the prevention of osteoporosis in glucocorticoid-treated patients. Arthritis Rheum 2005; 52: 2485-94.
20. INSTITUTE OF MEDICINE COMMITTEE ON QUALITY OF HEALTH CARE IN AMERICA: Shaping the Future of for Health. To Err is Human: Building A Safer Health System. Washington, DC, National Academy Press, 2000.
21. LEWIECKI EM: Pre-menopausal bone health assessment. Curr Rheumatol Rep 2005; 7: 46-52.
22. LIPTON A: The safety of zoledronic acid. Expert Opin Drug Saf 2007; 6: 305-13.
23. TANVETYANON T, STIFF PJ: Management of the adverse effects associated with intravenous bisphosphonates. Ann Oncol 2006; 17: 897-907.
24. JOHNELL O, KANIS JA, ODEN A et al.: Predictive value of BMD for hip and other fractures. J Bone Miner Res 2005; 20: 1185-94.
25. MARSHALL D, JOHNELL O, WEDEL H: Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 1996; 312: 1254-9.
26. DEN TONKELAAR I, ODDENS BJ: Determinants of long-term hormone replacement therapy and reasons for early discontinuation. Obstet Gynecol 2000; 95: 507-12.
27. ETTINGER B, PRESSMAN A: Continuation of post-menopausal hormone replacement therapy in a large health maintenance organization: Transdermal matrix patch versus oral estrogen therapy. Am J Manag Care 1999; 5: 779-85.
28. ETTINGER B, PRESSMAN A, SCHEIN J, CHAN J, SILVER P, CONNOLLY N: Alendronate use among 812 women: Prevalence of gastrointestinal complaints, non-compliance with patient instructions and discontinuation. J Managed Care Pharmacy 1998; 4: 488-92.
29. ETTINGER B, PRESSMAN A, SILVER P: Effect of age on reasons for initiation and discontinuation of hormone replacement therapy. Menopause 1999; 6: 282-9.
30. KAYSER J, ETTINGER B, PRESSMAN A: Post-menopausal hormonal support: Discontinuation of raloxifene versus estrogen. Menopause 2001; 8: 328-32.
31. TORGERSON DJ, DONALDSON C, RUSSELL IT, REID DM: Hormone replacement therapy: Compliance and cost after screening for osteoporosis. Eur J Obstet Gynecol Reprod Biol 1995; 59: 57-60.
32. MUDANO AS, CASEBEER L, PATINO F et al.: Racial disparities in osteoporosis prevention in a managed care population. South Med J 2003; 96: 445-51.
33. GANESAN K, PAN D, TEKLEHAIMENOT S, NORRIS K: Racial differences in institutionalization after hip fractures: California hospital discharge data. Ethn Dis 2005; 15 (Suppl. 5): S5-30-3.
34. GANESAN K, TEKLEHAIMANOT S, AKHTAR AJ, WIJEGUNARATNE J, THADEPALLI K, GANESAN N: Racial differences in preventive practices of African-American and Hispanic women. J Am Geriatr Soc 2003: 51: 515-8.
35. MIKULS TR, SAAG KG, GEORGE V, MUDANO AS, BANERJEE S: Racial disparities in the receipt of osteoporosis-related healthcare among community-dwelling older women with arthritis and previous fracture. J Rheumatol 2005; 32: 870-5.
36. MILLER RG, ASHAR BH, COHEN J et al.: Disparities in osteoporosis screening between at-risk African-American and white women. J Gen Intern Med 2005; 20: 847-51.
37. WEI GS, JACKSON JL, HERBERS JE JR: Ethnic disparity in the treatment of women with established low bone mass. J Am Med Wom Assoc 2003; 58: 173-7.
38. FURSTENBERG AL, MEZEY MD: Differences in outcome between black and white elderly hip fracture patients. J Chronic Dis 1987; 40: 931-8.
39. JACOBSEN SJ, GOLDBERG J, MILES TP, BRODY JA, STIERS W, RIMM AA: Race and sex differences in mortality following fracture of the hip. Am J Public Health 1992; 82: 1147-50.
40. KELLIE SE, BRODY JA: Sex-specific and race-specific hip fracture rates. Am J Public Health 1990; 80: 326-8.
41. MIKULS TR, SAAG KG, CURTIS J et al.: Prevalence of osteoporosis and osteopenia among African Americans with early rheumatoid arthritis: The impact of ethnic-specific normative data. J Natl Med Assoc 2005; 97: 1155-60.
42. CENTERS FOR DISEASE CONTROL AND PREVENTION: Fatalities and injuries from falls among older adults - United States, 1993-2003 and 2001-2005. MMMWR 2006; 55: 1221-4.
43. SEEMAN E, BIANCHI G, KHOSLA S, KANIS JA, ORWOLL E: Bone fragility in men - where are we? Osteoporos Int 2006; 17: 1577-83.
44. SOLOMON DH, BROOKHART MA, GANDHI TK et al.: Adherence with osteoporosis practice guidelines: A multi-level analysis of patient, physician, and practice setting characteristics. Am J Med 2004; 117: 919-24.
45. FELDSTEIN AC, ELMER PJ, SMITH DH: Electronic medical record reminder improves osteoporosis management after a fracture: A randomized, controlled trial. J Am Geriatr Soc 2006; 54: 450-7.
46. NEWMAN ED, AYOUB WT, STARKEY RH, DIEHL JM, WOOD GC: Osteoporosis disease management in a rural health care population: Hip fracture reduction and reduced costs in post-menopausal women after 5 years. Osteoporos Int 2003; 14: 146-51.
47. CUDDIHY MT, AMADIO PC, GABRIEL SE, PANKRATZ VS, KURLAND RL, MELTON LJ 3RD: A prospective clinical practice intervention to improve osteoporosis management following distal forearm fracture. Osteoporos Int 2004; 15: 695-700.
48. GARDNER MJ, BROPHY RH, DEMETRAKOPOULOS D et al.: Interventions to improve osteoporosis treatment following hip fracture. A prospective, randomized Trial. J Bone Joint Surg Am 2005; 87: 3-7.
49. STENVALL M, OLOFSSON B, LUNDSTROM M et al.: A multi-disciplinary, multi-factorial intervention program reduces post-operative falls and injuries after femoral neck fracture. Osteoporos Int 2007; 18: 167-75.
50. DAVIS DA, THOMSON MA, OXMAN AD, HAYNES RB: Evidence for the effectiveness of CME. A review of 50 randomized controlled trials. JAMA 1992; 268: 1111-7.
51. DAVIS DA, THOMSON MA, OXMAN AD, HAYNES RB: Changing physician performance. A systematic review of the effect of continuing medical education strategies. JAMA 1995; 274: 700-5.
52. MILLER GE: Continuing education for what? J Med Educ 1967; 42: 320-6.
53. PAZIRANDEH M: Does patient partnership in continuing medical education (CME) improve the outcome in osteoporosis management? J Contin Educ Health Prof 2002; 22: 142-51.
54. CHEVALLEY T, HOFFMEYER P, BONJOUR JP, RIZZOLI R: An osteoporosis clinical pathway for the medical management of patients with low-trauma fracture. Osteoporos Int 2002; 13: 450-5.
55. SILVERMAN SL, GREENWALD M, KLEIN RA, DRINKWATER BL: Effect of bone density information on decisions about hormone replacement therapy: A randomized trial. Obstet Gynecol 1997; 89: 321-5.
56. TORGERSON DJ, THOMAS RE, CAMPBELL MK, REID DM: Randomized trial of osteoporosis screening. Use of hormone replacement therapy and quality-of-life results. Arch Intern Med 1997; 157: 2121-5.
57. SOLOMON DH, POLINSKI JM, STEDMAN M et al.: Improving care of patients at-risk for osteoporosis: A randomized controlled trial. J Gen Intern Med 2007; 22: 362-7.
58. CURTIS JR, WESTFALL AO, ALLISON J et al.: Challenges in improving the quality of osteoporosis care for long-term glucocorticoid users: A prospective randomized trial. Arch Intern Med 2007; 167: 591-6.
59. SOLOMON D, KATZ J, LA TOURETTE A, COBLYN J: Multi-faceted intervention to improve rheumatologists' management of glucocorticoid-induced osteoporosis: A randomized controlled trial. Arthritis Rheum 2004; 51: 383-7.
60. NAUNTON M, PETERSON GM, JONES G, GRIFFIN GM, BLEASEL MD: Multi-faceted educational program increases prescribing of preventive medication for corticosteroid-induced osteoporosis. J Rheumatol 2004; 31: 550-6.
61. http://www.surgeongeneral.gov/library/bonehealth/.
62. Clinical Guidelines. Screening for osteoporosis in post-menopausal women: Recommendations and rationale, U.S. Preventative Task Force. Ann Intern Med 2002; 137: 526-8.
63. SOLOMON DH, CONNELLY MT, ROSEN CJ et al.: Factors related to the use of bone densitometry: Survey responses of 494 primary care physicians in New England. Osteoporos Int 2003; 14: 123-9.
64. CARO JJ, ISHAK KJ, HUYBRECHTS KF, RAGGIO G, NAUJOKS C: The impact of compliance with osteoporosis therapy on fracture rates in actual practice. Osteoporos Int 2004; 15: 1003-8.
65. HARRINGTON JT, DEAL CL: Successes and failures in improving osteoporosis care after fragility fracture: Results of a multiple-site clinical improvement project. Arthritis Rheum 2006; 55: 724-8.